CYSB2300093 | 硫培非格司亭注射液 | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor | Injection | Biological Products | Supplementary Application | 2023-05-10 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CYSB2300015 | 硫培非格司亭注射液 | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor | Injection | Biological Products | Supplementary Application | 2023-01-18 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CYSB2200259 | 硫培非格司亭注射液 | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor | Injection | Biological Products | Supplementary Application | 2022-11-15 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CYSB2200111 | 硫培非格司亭注射液 | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor | Injection | Biological Products | Supplementary Application | 2022-04-27 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXSB2200022 | 硫培非格司亭注射液 | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor | Injection | Biological Products | Supplementary Application | 2022-02-14 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
CXSS1700005 | 硫培非格司亭注射液 | PEGylated Recombinant Human Granulocyte Colony-Stimulating Factor | Injection | Biological Products(9) | New Drug Application | 2017-03-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2018-05-17 | view |